Low-Doses Of Isobaric Bupivacaine On Intraoperative Hemodynamics In Spinal Anesthesia During Cesarean Section
Comparison Of The Effects Of Two Different Low-Doses Of Isobaric Bupivacaine On Intraoperative Hemodynamics In Spinal Anesthesia During Cesarean Section: A Randomized Controlled Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
The primary aim of this study was to compare the effects of two different low-dose bupivacaine used in spinal anesthesia on intraoperative hemodynamics in cesarean section operations.Investigators think that low-dose bupivacaine and fentanyl mixture applied in cesarean section cause fewer hemodynamic changes,provide adequate anesthesia and analgesia quality,cause fewer side effects,and postoperatively,patients may return to their daily activities more quickly.This study was conducted on 80 pregnant women undergo an elective cesarean section.Patients were randomly allocated in GrupA and GroupB. Combined spinal-epidural anesthesia was performed in the sitting position using the needle-inside-needle technique.After cerebrospinal fluid flow was observed, GroupA patients were given a solution containing 5 mg isobaric bupivacaine+15 µg fentanyl (1.3 ml),and Group B was administered a solution containing 7 mg isobaric bupivacaine+15 µg fentanyl (1.7ml).Hypotension,bradycardia,duration of analgesia,postoperative nausea and vomiting were recorded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2019
CompletedFirst Submitted
Initial submission to the registry
October 21, 2021
CompletedFirst Posted
Study publicly available on registry
November 26, 2021
CompletedDecember 8, 2021
November 1, 2021
8 months
October 21, 2021
November 25, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary aim of study was to compare the effects of two different low-dose bupivacaine used in spinal anesthesia on intraoperative systolic and diastolic blood pressure (mmHg) in cesarean section operations.
Intraoperatif hemodynamics
during cesarean procedure
Study Arms (2)
Group İzobarik bupivakain (5 mg) + fentanil
ACTIVE COMPARATORPatients were given a solution containing 5 mg isobaric bupivacaine + 15 µg fentanyl (1.3 ml)
Group İzobarik bupivakain (7 mg) + fentanil
ACTIVE COMPARATORPatients were givena solution containing 7 mg isobaric bupivacaine + 15 µg fentanyl (1.7 ml)
Interventions
Two Different Low-Doses Of Isobaric Bupivacaine ( Group İzobarik bupivakain (5 mg) + fentanil and Group İzobarik bupivakain (7 mg)+ fentanyl ) were administered to the subarachnoid space
Eligibility Criteria
You may qualify if:
- ASA I-II
- Pregnant women
- years of age
- BMI\<40kg/m2
- cm in height
You may not qualify if:
- Patients with hypertension induced by emergency obstetric surgery
- Significant systemic disease,
- Multiple pregnancies,
- Fetal or placental abnormality,
- Hypersensitivity or allergy history to the drugs to be used in the study
- Contraindicated neuraxial anesthesia,
- Infection at or around the region to be anesthetized,
- Coagulation abnormalities
- Patients unable to decide or unwilling to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aysenur Dostbil
Yakutiye, Erzurum, 25000, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mehmet Aksoy, MD
Ataturk University, Department of Anesthesiology and Reanimation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 21, 2021
First Posted
November 26, 2021
Study Start
October 15, 2018
Primary Completion
June 15, 2019
Study Completion
June 15, 2019
Last Updated
December 8, 2021
Record last verified: 2021-11